Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine

Journal of Medical Virology

Volumn 63, Issue 4, 2001, Pages 305-310

  Sormunen, H ^a   Stenvik, M ^a   Eskola, J ^a   Hovi, T ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Dose interval; Inactivated poliovirus vaccine; Maternal antibodies

Indexed keywords

INACTIVATED VACCINE; POLIO NOVUM; POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; INFANT; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; VACCINATION;

AGE FACTORS; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; VACCINATION;

POLIOVIRUS;

EID: 0035127593     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200104)63:4<305::AID-JMV1006>3.0.CO;2-U     Document Type: Article

References (13)

1. Poliomyelitis prevention in the United States: Introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2. Revised recommendations for routine poliomyelitis vaccination. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
3. Simultaneous injection of hepatitis B vaccine with BCG and killed poliovirus vaccine
4. Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccines
5. Safety and immunogenicity in young infants of Haemophilus b tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis enhanced inactivated poliovirus vaccine
6. Simultaneous administration of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood
7. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine
8. Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine
9. Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine
10. Primary immunization with combined acellular DTaP-IPV-Act-HIB vaccine given at 2-3-4 or 2-4-6 months of age
11. Intestinal trypsin can significantly modify, antigenic properties of polioviruses: Implications for the use of inactivated poliovirus vaccine
12. Cleavage of VP1 and modification of antigenic site 1 of type 2 polloviruses by intestinal trypsin
13. Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine